NewEdge Advisors’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5
Closed -$24 4143
2025
Q1
$24 Sell
5
-15,765
-100% -$91.8K ﹤0.01% 3886
2024
Q4
$109K Buy
+15,770
New +$116K ﹤0.01% 2249
2023
Q2
Sell
-280
Closed -$1.46K 3624
2023
Q1
$1.46K Sell
280
-175
-38% -$1.26K ﹤0.01% 3097
2022
Q4
$1.3K Buy
+455
New +$4.1K ﹤0.01% 2954

Other funds holding SRTS

NewEdge Advisors's SRTS Position: Q2 2025 in Review

NewEdge Advisors sold out of Sensus Healthcare (SRTS) in Q2 2025, closing a stake of 5 shares — an estimated $24 sold.

NewEdge Advisors first reported a position in SRTS in Q4 2022 and held it in 4 quarters. The position peaked at $109K in Q4 2024. 46 funds tracked by Wall St. Rank hold SRTS as of Q2 2025.

  • NewEdge Advisors reported no remaining Sensus Healthcare position as of Q2 2025 after selling out during the quarter.
  • NewEdge Advisors sold 5 Sensus Healthcare shares in Q2 2025, an estimated $24.
  • NewEdge Advisors first reported a position in Sensus Healthcare in Q4 2022 and held it in 4 quarters.
  • NewEdge Advisors's Sensus Healthcare position peaked at $109K in Q4 2024.
  • 46 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2025.

Based on NewEdge Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.